Imipramine N-Glucuronidation in Human Liver Microsomes: Biphasic Kinetics and Characterization of UDP-Glucuronosyltransferase Isoforms
- 1 June 2002
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 30 (6) , 636-642
- https://doi.org/10.1124/dmd.30.6.636
Abstract
A method for the direct determination of imipramineN-glucuronidation in human liver microsomes by high-performance liquid chromatography with UV detection was developed. Imipramine was incubated with human liver microsomes and UDP-glucuronic acid. The Eadie-Hofstee plots of imipramineN-glucuronidation in human liver microsomes were biphasic. For the high-affinity component, theKm was 97.2 ± 39.4 μM and theVmax was 0.29 ± 0.03 nmol/min/mg of protein. For the low-affinity component, theKm was 0.70 ± 0.29 mM and theVmax was 0.90 ± 0.28 nmol/min/mg of protein. The imipramine N-glucuronosyltransferase activities were not detectable in two samples of human jejunum microsomes. Among recombinant UDP-glucuronosyltransferases (UGTs) in baculovirus-infected insect cells (Supersomes or Bacurosomes) or human B-lymphoblastoid cells tested in the present study (UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A8, UGT1A9, UGT1A10, UGT2B7, and UGT2B15), only UGT1A4 showed imipramineN-glucuronosyltransferase activity. The activity in UGT1A4 Supersomes was higher than that in recombinant UGT1A4 expressed in human B-lymphoblastoid cells at all imipramine concentration tested. The kinetics of imipramine N-glucuronidation in UGT1A4 Supersomes did not fit the Michaelis-Menten plot, showing aKm of >1 mM. In contrast, in UGT1A4 expressed in human B-lymphoblastoid cells,Km was 0.71 ± 0.36 mM and theVmax was 0.11 ± 0.03 nmol/min/mg of protein. Interindividual differences in the imipramineN-glucuronidation in liver microsomes from 14 humans were at most 2.5-fold. The imipramineN-glucuronosyltransferase activities in 11 human liver microsomes were significantly (r = 0.817,P < 0.005) correlated with the glucuronosyltransferase activities of trifluoperazine, a typical substrate of UGT1A4. This is the first report of the biphasic kinetics of imipramine N-glucuronide in human liver microsomes.Keywords
This publication has 14 references indexed in Scilit:
- Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locusPharmacogenetics, 2001
- Polymorphic Gene Regulation and Interindividual Variation of UDP-glucuronosyltransferase Activity in Human Small IntestineJournal of Biological Chemistry, 2000
- UDP-glucuronosyltransferase activity in human liver and colonGastroenterology, 1999
- STRUCTURAL AND FUNCTIONAL STUDIES OF UDP-GLUCURONOSYLTRANSFERASES*Drug Metabolism Reviews, 1999
- The Glucuronidation of Exogenous and Endogenous Compounds by Stably Expressed Rat and Human UDP-Glucuronosyltransferase 1.1Archives of Biochemistry and Biophysics, 1996
- N+-Glucuronidation of aliphatic tertiary amines in human: antidepressant versus antipsychotic drugsXenobiotica, 1995
- Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidationBiochemical Journal, 1994
- Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferases of the UGT1 gene complexCarcinogenesis: Integrative Cancer Research, 1994
- Glucuronidation of imipramine in rabbit and human liver microsomes: assay conditions and interaction with other tertiary amine drugsBiochemical Pharmacology, 1991
- Drug glucuronidation in humansPharmacology & Therapeutics, 1991